Cheney Research » artesunate

Artemisins as therapy in CFS

pcheney — Fri, 20 Nov 2009 17:01:22 +0000

Before we learned that Artesunate might inhibit XMRV via NF Kappa B inhibition in August of 2009, we were aware that Artesunate was a known inhibitor of all known human herpes viruses against which it has been tested as well as HIV. I was first introduced to Artesunate by a prominent Autism expert at a medical conference who finds it helpful in Autism. We were also impressed that Artesunate and its relative Wormwood, using SL administration on the echo table, produced the most powerful ablation of oxygen toxicity as well as the ablation of other echo terrain map (ETM) backflashes than any other therapy we have ever used. Both Artesunate and Wormwood will do this in 30 seconds.

Cell Signaling Factors- Clinical Strategies Update-April 2009

pcheney — Wed, 15 Apr 2009 22:46:06 +0000

This treatment update discusses the uses and various strategies to improve the effectiveness of cell signaling factors based on actual clinical examples and patient experiences. Both positive and negative results are discussed and practical solutions to improve outcomes are detailed.

Artesunate Complications

pcheney — Mon, 13 Apr 2009 22:38:12 +0000

A colleague reported an exacerbation of pre-existing skin lesions in a patient on Artesunate. This case is complicated by the use of antibiotic creams as well as steroid creams that complicates the potential association of Artesunate with this skin problem

Oxidative Therapies vs. Anti-Oxidative Therapies

pcheney — Sun, 12 Apr 2009 22:33:14 +0000

In regards to powerful anti-oxidative therapies, I have been wondering about the disadvantages of NF Kappa B inhibition (ie Artesunate) if it is too strong. My sense is that extracellular microbial (aka bacterial) protection might be more compromised than intracellular